期刊文献+

Bcl-2与急性白血病患者骨髓组织血管新生的关系 被引量:3

Relationship of BCL-2 with bone marrow angiogenesis in patients with acute leukemia
下载PDF
导出
摘要 目的通过检测急性白血病(AL)患者骨髓病理切片中血管内皮生长因子(Vascular Endothelial Growth Factor,VEGF)及Bcl-2蛋白的表达和微血管的生成情况及VEGF及Bcl-2蛋白的表达和微血管生成之间的相关性。方法免疫组织化学染色方法检测35例AL患者和35例对照组骨髓病理切片中的,Bcl-2表达;ELISA检测患者血清中VEGF-C的表达。结果对照组患者血清中VEGF-C为(126.34±21.22)pg/ml,实验组患者血清中VEGF-C为(324.45±34.12)pg/ml,35例AL患者,微血管密度(microvessel density,MVD)的平均光密度值为(0.3573±0.030)。35例对照组骨髓病理免疫组织化学片中,MVD的平均光密度值为(0.2192±0.037)。AL患者的MVD平均光密度值明显高于对照组,有显著性差异。结论 AL患者的骨髓组织中由于VEGF的表达,诱导产生更多的Bcl-2蛋白来降低AL细胞凋亡,从而增加AL的恶性程度。 Objective To detect the vascular endothelial growth factor(Vascular Endothelial Growth Factor,VEGF)and Bcl-2 protein expression in bone marrow biopsy of patients with acute leukemia,to investigate the microvessel formation conditions,and to explore the correlation between VEGF and Bcl-2 protein expression and the angiogenesis.Method Immunohistochemical staining method were used to detect the expression of Bcl-2 in the bone marrow biopsy of 35 cases of acute leukemia and 35 cases in control;ELISA were used to detect their serum VEGF-C expression.Results The serum VEGF-C is(126.34±21.22)pg/ml in control group,and(324.45 ±34.12)pg/ml in experimental group.As for the microvessel density(MVD),the average optical density value is(0.3573±0.030)for 35 patients with acute leukemia,but is(0.2192±0.037)in bone marrow pathology immunohistochemistry film of 35 cases in control group.The average optical density value of MVD in patients with acute leukemia was remarkably higher than that in control group,with a significant difference.Conclusion The expression of VEGF in acute leukemia bone marrow tissue induced more Bcl-2 protein to reduce the apoptosis of acute leukemia cells,thereby it increases the malignancy degree of acute leukemia.
出处 《肿瘤药学》 CAS 2011年第6期508-510,523,共4页 Anti-Tumor Pharmacy
关键词 AL 血管内皮生长因子 血管新生 BCL-2 免疫组织化学 Acute Leukemia Vascular Endothelial Growth Factor Angiogenesis Bcl-2 Immunohistochemistry
  • 相关文献

参考文献10

  • 1姜孝新,伍小平,蒋艳,李艳雯.NF-κB p65、VEGF在肝细胞癌中的表达及临床意义[J].肿瘤药学,2011,1(3):173-176. 被引量:9
  • 2刘曦.胰腺癌中MMP-2、VEGF-D的表达及意义[J].肿瘤药学,2011,1(3):177-182. 被引量:6
  • 3易晓雷,李旭辉,冯留顺,骆红,苗雄鹰.VEGF-D和CD105在胰腺癌中的表达及意义[J].现代生物医学进展,2009,9(23):4500-4503. 被引量:3
  • 4许子亮,韩中朝.VEGF与血液学恶性疾病[J].国际病理科学与临床杂志,2006,26(4):318-320. 被引量:8
  • 5S. Shivakumar,B. T. Prabhakar,K. Jayashree,M. G. R. Rajan,Bharathi P. Salimath.Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast[J]. Journal of Cancer Research and Clinical Oncology . 2009 (4)
  • 6Arigami T,,Natsugoe S,Uenosono Y,et al.Vascular endothe-lial growth factor-C and-D expression correlates with lymph node micrometastasis in pN0early ICC. Journal of Surgical Oncology . 2009
  • 7Aguayo A,Kantarjian H,Manshouri T,et al.Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood . 2000
  • 8Niki T,Iba S,Tokunou M,et al.Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clinical Cancer Research . 2000
  • 9Perez-Atayde AR,Sallan SE,Tedrow U,et al.Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. American Journal of Pathology . 1997
  • 10Padro T,Ruiz S,Bieker R,et al.Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood . 2000

二级参考文献35

  • 1Andreas Pircher,Michael Medinger,Joachim Drevs.Liver cancer:Targeted future options[J].World Journal of Hepatology,2011,3(2):38-44. 被引量:7
  • 2Kerbel RS,Klement G,Pritchard KI,et al.Continuous low-dose anti-angiogenic/metronomic chemotherapy:from the research laboratory into the oncology clinic[J].Ann Oncol,2002,13(1):12-15.
  • 3Keck PJ,Hauser SD,Krivi G,et al.Vascular permeability factor,an endothelial cell mitogen related to PDGF[J].Science,1989,246(4935):1309-1312.
  • 4Ferrara N,Gerber HP,LeCouter J.The biology of VEGF and its receptors[J].Nat Med,2003,9(6):669-676.
  • 5Podar K,Tai YT,Davies FE,et al.Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration[J].Blood,2001,98(2):428-435.
  • 6Aoki Y,Tosato G.Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas[J].Leuk Lymphoma,2001,41:229-237.
  • 7Shweiki D,Itin A,Soffer D,et al.Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis[J].Nature,1992,359 (6398):843-845.
  • 8Kerbel R,Folkman J.Clinical translation of angiogenesis inhibitors[J].Nat Rev Cancer,2002,2(10):727-739.
  • 9Millauer B,Wizigmann-Voos S,Schnurch H,et al.High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis[J].Cell,1993,72 (6):835-846.
  • 10Gerber HP,Malik AK,Solar GP,et al.VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism[J].Nature,2002,417(6892):954-958.

共引文献21

同被引文献11

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部